GSK leads drugmakers’ fight against superbugs
Clive Cookson, Science Editor of The Financial Times, reports on the companies who are most active in curbing AMR. Cookson covers the Antimicrobial Resistance Benchmark, focusing on the key findings on the performance of large research-based pharmaceutical companies, generic medicine manufacturers and biopharmaceutical companies in the scope of analysis.
Date
23 January 2018